Cerevel Therapeutics Holdings Inc (DELISTED) (CERE:DL)
44.96
0.00 (0.00%)
USD |
NASDAQ |
Aug 01, 16:00
Cerevel Therapeutics Holdings Total Assets (Quarterly): 1.127B for March 31, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 1.127B |
| December 31, 2023 | 1.243B |
| September 30, 2023 | 821.96M |
| June 30, 2023 | 894.35M |
| March 31, 2023 | 930.34M |
| December 31, 2022 | 1.018B |
| September 30, 2022 | 1.094B |
| June 30, 2022 | 596.66M |
| Date | Value |
|---|---|
| March 31, 2022 | 618.55M |
| December 31, 2021 | 688.92M |
| September 30, 2021 | 733.48M |
| June 30, 2021 | 391.00M |
| March 31, 2021 | 408.10M |
| December 31, 2020 | 445.27M |
| September 30, 2020 | 150.52M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
150.52M
Minimum
Sep 2020
1.243B
Maximum
Dec 2023
744.09M
Average
733.48M
Median
Sep 2021
Total Assets (Quarterly) Benchmarks
| AbbVie Inc | 143.42B |
| Amgen Inc | 90.88B |
| Biogen Inc | 28.31B |
| Gilead Sciences Inc | 54.52B |
| Eli Lilly and Co | 75.61B |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 562.89M |
| Shareholders Equity (Quarterly) | 564.46M |